Abstract
Nuclear and near-infrared fluorescence (NIRF) imaging provide non-invasive monitoring of disease. Merging the respective contrast agents through dual labeling could facilitate NIRF validation using proven nuclear imaging methodology while expanding the utility of diagnostic radiotracers.
© 2013 Optical Society of America
PDF Article | Presentation VideoMore Like This
Eva M. Sevick-Muraca, Banghe Zhu, Barrett R. Harvey, Mary A. Hall, Kenneth L. Pinkston, Nathaniel Wilganowski, Holly Robinson, and Ali Azhdarinia
JM3A.1 Bio-Optics: Design and Application (BODA) 2013
Henry F. VanBrocklin
JM3A.4 Bio-Optics: Design and Application (BODA) 2013
Yujie Lu, I-Chih Tan, Chinmay Darne, Nathaniel Wilganowski, Holly Robinson, John Rasmussen, Shikui Yan, Anne M. Smith, and Eva M. Sevick-Muraca
BTu4A.4 Biomedical Optics (BIOMED) 2012